SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bank of New York/ADR Division – ‘F-6 POS’ on 4/19/18 re: Fresenius Medical Care AG & Co. KGaA

On:  Thursday, 4/19/18, at 2:01pm ET   ·   Effective:  4/19/18   ·   Accession #:  1019155-18-98   ·   File #:  333-140664

Previous ‘F-6 POS’:  ‘F-6 POS’ on 4/18/18   ·   Next:  ‘F-6 POS’ on 4/25/18   ·   Latest:  ‘F-6 POS’ on 4/12/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/19/18  Bank of New York/ADR Division     F-6 POS     4/19/18    2:264K Fresenius Medical Care AG &… KGaA Emmet Marvin & Mart… LLP

Post-Effective Amendment to an F-6   —   Form F-6
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-6 POS     Post Effective Amendment No. 1 to the Form F-6      HTML     28K 
 2: EX-1        Form of Deposit Agreement                           HTML    171K 


F-6 POS   —   Post Effective Amendment No. 1 to the Form F-6


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

As filed with the Securities and Exchange Commission on April 19, 2018

Registration No. 333-140664

_____________________

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________

POST EFFECTIVE AMENDMENT NO. 1 TO THE

FORM F-6

REGISTRATION STATEMENT

under

THE SECURITIES ACT OF 1933

For American Depositary Shares

of

 

Fresenius Medical Care AG & CO. KGaA

(Exact name of issuer of deposited securities as specified in its charter)

N/A

(Translation of issuer's name into English)

 

Federal Republic of Germany

(Jurisdiction of incorporation or organization of issuer)

 

THE BANK OF NEW YORK MELLON

(Exact name of depositary as specified in its charter)

225 Liberty Street, New York, New York 10286

(212) 495-1784

(Address, including zip code, and telephone number, including area code, of depositary's principal executive offices)

_______________________

The Bank of New York Mellon

ADR Division

225 Liberty Street, 21st Floor

New York, New York 10286

(212) 495-1784

(Address, including zip code, and telephone number, including area code, of agent for service)

 

Copies to:

Brian D. Obergfell, Esq.

Emmet, Marvin & Martin, LLP

120 Broadway

New York, New York 10271

(212) 238-3032

It is proposed that this filing become effective under Rule 466

[ ] immediately upon filing

[ ] on (Date) at (Time).

If a separate registration statement has been filed to register the deposited shares, check the following box. [ ]

 

 
 

The prospectus consists of the proposed Form of American Depositary Receipt included as Exhibit A to the Form of Deposit Agreement filed as Exhibit 1 to this Registration Statement which is incorporated herein by reference.

 
 

PART I

INFORMATION REQUIRED IN PROSPECTUS

 

Item -1. Description of Securities to be Registered

 

Cross Reference Sheet

 

 

Item Number and Caption

 

 

Location in Form of Receipt Filed Herewith as Prospectus

 

1.       Name and address of depositary

 

  Introductory Article

2.       Title of American Depositary Receipts and identity of deposited securities

 

  Face of Receipt, top center

Terms of Deposit:

 

   
(i)   The amount of deposited securities represented by one unit of American Depositary Receipts   Face of Receipt, upper right corner
(ii)   The procedure for voting, if any, the deposited securities   Articles number 15, 16 and 18
(iii)   The collection and distribution of dividends   Articles number 4, 12, 13, 15 and 18
(iv)  The transmission of notices, reports and proxy soliciting material   Articles number 11, 15, 16 and 18
(v)   The sale or exercise of rights   Articles number 13, 14, 15 and 18
(vi)  The deposit or sale of securities resulting from dividends, splits or plans of reorganization   Articles number 12, 13, 15, 17 and 18
(vii)  Amendment, extension or termination of the deposit agreement   Articles number 20 and 21
(viii)  Rights of holders of Receipts to inspect the transfer books of the depositary and the list of holders of Receipts   Article number 11
(ix)  Restrictions upon the right to deposit or withdraw the underlying securities   Articles number 2, 3, 4, 5, 6, 8 and 22
(x)   Limitation upon the liability of the depositary   Articles number 14, 18, 19 and 21

3.       Fees and Charges

 

  Articles 7 and 8
  Item - 2. Available Information    
    Public reports furnished by issuer   Article number 11
         
 
 

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

Item - 3. Exhibits

a. Form of Amended and Restated Deposit Agreement dated as of ____________, 2018, among Fresenius Medical Care AG & Co. KGaA, The Bank of New York Mellon as Depositary, and all Owners and Holders from time to time of American Depositary Shares issued thereunder. - Filed herewith as Exhibit 1.
b. Form of Letter Agreement dated December 8, 2006, among Fresenius Medical Care AG & Co. KGaA, JPMorgan Chase Bank, N.A., and The Bank of New York. – Previously filed.
c. Every material contract relating to the deposited securities between the Depositary and the issuer of the deposited securities in effect at any time within the last three years. - See (a) and (b) above.
d. Opinion of Emmet, Marvin & Martin, LLP, counsel for the Depositary, as to legality of the securities to be registered. – Previously filed.  
e. Certification under Rule 466. - Not Applicable.
   

 

Item - 4.

Undertakings

 

(a) The Depositary hereby undertakes to make available at the principal office of the Depositary in the United States, for inspection by holders of the ADSs, any reports and communications received from the issuer of the deposited securities which are both (1) received by the Depositary as the holder of the deposited securities, and (2) made generally available to the holders of the underlying securities by the issuer.

 

(b) If the amounts of fees charged are not disclosed in the prospectus, the Depositary undertakes to prepare a separate document stating the amount of any fee charged and describing the service for which it is charged and to deliver promptly a copy of such fee schedule without charge to anyone upon request. The Depositary undertakes to notify each registered holder of an ADS thirty days before any change in the fee schedule.
 
 

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on April 19, 2018.

 

Legal entity created by the agreement for the issuance of American Depositary Shares for ordinary bearer shares of Fresenius Medical Care AG & Co. KGaA

By: The Bank of New York Mellon,

As Depositary

 

 

By: /s/ Lance Miller

Name: Lance Miller

Title: Vice President

 
 

Pursuant to the requirements of the Securities Act of 1933, Fresenius Medical Care AG & Co. KGaA has caused this Registration Statement to be signed on its behalf by the undersigned thereunto duly authorized, in the City of Bad Homburg, Federal Republic of Germany on April 19, 2018.

Fresenius Medical Care AG & Co. KGaA, a partnership limited by shares, represented by

 

Fresenius Medical Care Management AG, its general partner

By:

/s/ Rice Powell

Name: Rice Powell
Title: Chief Executive Officer and Chairman of the
  Management Board of the General Partner
   
   
   
By:

/s/ Michael Brosnan

Name: Michael Brosnan
Title: Member of the Management Board of the General
  Partner

 

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities indicated on April 19, 2018.

 

/s/ Rice Powell

 

/s/ Michael Brosnan

Rice Powell   Michael Brosnan
Chief Executive Officer and Member of the   Chief Financial Officer and Member of the
Management Board of the General Partner   Management Board of the General Partner
    and Authorized U.S. Representative
     
     
     
     

 

 

/s/ Josef Dinger

William Valle   Josef Dinger
Member of the Management Board of the General   Principal Accounting Officer
Partner    
     
     

/s/ Olaf Schermeier

   
Olaf Schermeier    
Member of the Management Board of the General    
Partner    
     
     

/s/ Kent Wanzek

   
Kent Wanzek    
Member of the Management Board of the General    
Partner    
     
     

 

   
Harry de Wit    
Member of the Management Board of the General    
Partner    
     

 

 
 

 

INDEX TO EXHIBITS

Exhibit

Number Exhibit

 

1 Form of Amended and Restated Deposit Agreement dated as of ____________, 2018, among Fresenius Medical Care AG & Co. KGaA, The Bank of New York Mellon as Depositary, and all Owners and Holders from time to time of American Depositary Shares issued thereunder.
   

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘F-6 POS’ Filing    Date    Other Filings
Filed on / Effective on:4/19/186-K
12/8/06
 List all Filings 
Top
Filing Submission 0001019155-18-000098   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 4, 10:18:19.1am ET